PCSK9 Forum
Click here to forward this email to a colleague
Facebook Twitter RSS YouTube linkedin
Home  |  About  |  PCSK9  |  News  |  Commentary  |  Trials  |  Videos  |  Resources  |  Contact
NOW AVAILABLE:
Background slide resources from PCSK9 Forum:
PCSK9 as a therapeutic target

As part of the continuing professional education slide resource programme, PCSK9 Forum announces the next in the series of complementary slide decks.

Why is PCSK9 an ideal target to improve LDL cholesterol goal attainment?

PCSK9 (proprotein convertase subtilisin/kexin type 9) is a key player in the regulation of circulating LDL cholesterol levels. Over 15 years ago, researchers showed that individuals with mutations in the PCSK9 gene associated with gain of PCSK9 activity were at increased risk of premature cardiovascular disease due to very high cholesterol levels. This finding provided the impetus for the search for novel agents targeting PCSK9: the PCSK9 revolution.

The latest complementary slide resource from PCSK9 Forum discusses the evidence for PCSK9 as a novel therapeutic target in very high risk patients, and provides an accessible resource for clinicians in their routine practice.

PCSK9 Background Slides

Click to view »


Bookmark PCSK9 Forum to return for regular updates to this innovative expert-led educational slide resource programme.


Like us on Facebook
For the latest updates, PCSK9 news and analysis.
Follow us on Twitter
Hot topics, news and conference reports.
YouTube Channel
For videos, interviews and webcasts from leading experts.
Download Now: New Slide Deck Programme

First two decks focusing on the main results from FOURIER and ODYSSEY OUTCOMES

DOWNLOAD THEM NOW »

Register now at www.pcsk9forum.org to access our new slide deck programme.
Questions & Answers

Why are new treatments needed?


Read the full answer and other questions on the PCSK9 Forum »
Educational Partners
and Supporters
Amgen The Medicines Company Sanofi
Copyright PCSK9 Forum 2019. Please click here to unsubscribe from future mailings.